Literature DB >> 24132831

Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by β-amyloid through activation of SIRT1/Akt1 pathway.

Jing Zhang1, Xiaowen Feng, Jintao Wu, Hongyan Xu, Guibao Li, Dexiao Zhu, Qingwei Yue, Haili Liu, Yi Zhang, Dong Sun, Hui Wang, Jinhao Sun.   

Abstract

Resveratrol (3,5,4'-tihydroxy-trans-stilbene), a polyphenolic phytoalexin found in the skin and seeds of grapes, has been reported to possess a wide range of biological and pharmacological activities including antioxidant, anti-inflammatory, and antimutagenic effects. The present study intended to explore the neuroprotective effects of resveratrol against Aβ25-35 -induced neurotoxicity of cultured mouse cortical neurons and the possible mechanisms involved. For this purpose, mouse cortical neurons were cultured and exposed to 30 μM Aβ25-35 in the absence or presence of resveratrol (5, 10, and 25 μM). In addition, the potential contribution of the SIRT1/Akt1 neuroprotective pathway in resveratrol-mediated protection against Aβ25-35 -induced neurotoxicity was also investigated. The results showed that resveratrol dose-dependently increased cell viability and reduced the number of apoptotic cells as measured by 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay, lactate dehydrogenase (LDH) activity assay, reactive oxygen species (ROS) activity assay, and Hoechst/PI double staining. Further study revealed that resveratrol through activation of SIRT1/Akt1 to avert apoptosis. These findings raise the possibility that resveratrol may be a potent therapeutic compound against the neurodegenerative diseases.
© 2013 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt1; SIRT1; apoptosis; cortical neurons; resveratrol

Mesh:

Substances:

Year:  2013        PMID: 24132831     DOI: 10.1002/biof.1149

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  19 in total

Review 1.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

Review 2.  Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 3.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

4.  SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 5.  WISP1: Clinical insights for a proliferative and restorative member of the CCN family.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014       Impact factor: 1.990

6.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

7.  Resveratrol prevents cadmium activation of Erk1/2 and JNK pathways from neuronal cell death via protein phosphatases 2A and 5.

Authors:  Chunxiao Liu; Ruijie Zhang; Chenxia Sun; Hai Zhang; Chong Xu; Wen Liu; Wei Gao; Shile Huang; Long Chen
Journal:  J Neurochem       Date:  2015-09-02       Impact factor: 5.546

Review 8.  New Insights for Oxidative Stress and Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Oxid Med Cell Longev       Date:  2015-05-12       Impact factor: 6.543

9.  Resveratrol Protects PC12 Cell against 6-OHDA Damage via CXCR4 Signaling Pathway.

Authors:  Jing Zhang; Wenchuang Fan; Hui Wang; Lihua Bao; Guibao Li; Tao Li; Shouyang Song; Hongyu Li; Jing Hao; Jinhao Sun
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-22       Impact factor: 2.629

10.  MicroRNAs and SIRT1: A Strategy for Stem Cell Renewal and Clinical Development?

Authors:  Kenneth Maiese
Journal:  J Transl Sci       Date:  2015-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.